Brief: Ironwood To Present New Data Reinforcing Impact Of Linaclotide On Functional Constipation In Children And Adolescents At Naspghan Annual Meeting
05/10/2023 12:42
Oct 5 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O :
* IRONWOOD TO PRESENT NEW DATA AT NASPGHAN ANNUAL MEETING
REINFORCING IMPACT OF LINACLOTIDE ON FUNCTIONAL CONSTIPATION IN
CHILDREN AND ADOLESCENTS AGES 6-17 YEARS-OLD
* : DATA DEMONSTRATES THAT LINACLOTIDE REDUCES NEED FOR
RESCUE
MEDICATIONS IN THIS PATIENT POPULATION
Source text for Eikon: ID:nBw5Fcpx4a
Further company coverage: IRWD.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation